Nanomedicine Scale-up Technologies: Feasibilities and Challenges

Ageing International

Volumn 15, Issue 6, 2014, Pages 1527-1534

  Paliwal, Rishi ^a   Babu, R Jayachandra ^b   Palakurthi, Srinath ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b AUBURN UNIVERSITY   (United States)

Author keywords

lipid nanoparticles; nanomedicine; polymeric nanoparticles; scale up production

Indexed keywords

DRUG; DRUG CARRIER; EXCIPIENT; NANOPARTICLE; POLYMER;

CHEMISTRY; MEDICINAL CHEMISTRY; NANOMEDICINE; PHARMACEUTICS; PROCEDURES; QUALITY CONTROL; STANDARDS;

CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; EXCIPIENTS; NANOMEDICINE; NANOPARTICLES; PHARMACEUTICAL PREPARATIONS; POLYMERS; QUALITY CONTROL; TECHNOLOGY, PHARMACEUTICAL;

EID: 84912127307     PISSN: 01635158     EISSN: 1936606X     Source Type: Journal    
DOI: 10.1208/s12249-014-0177-9     Document Type: Review

References (46)

1. Hughes GA. Nanostructure-mediated drug delivery. Nanomedicine. 2005;1:22–30.
2. Ladj R, Bitar A, Eissa MM, Fessi H, Mugnier Y, Le Dantec R, et al. Polymer encapsulation of inorganic nanoparticles for biomedical applications. Int J Pharm. 2013;458(1):230–41.
3. Tang L, Cheng J. Nonporous silica nanoparticles for nanomedicine application. Nano Today. 2013;8:290–12.
4. Khan MS, Vishakante GD, Siddaramaiah H. Gold nanoparticles: a paradigm shift in biomedical applications. Adv Colloid Interface Sci. 2013;199–200:44–58.
5. Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev. 2004;56:1649–59.
6. Langer R. Drug delivery and targeting. Nature. 1998;392:5–10.
7. Junghanns JAH, Müller RH. Nanocrystal technology, drug delivery and clinical applications. Int J Nanomedicine. 2008;3:295–310.
8. Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov. 2010;9:615–27.
9. Merisko-Liversidge E, Liversidge GG, Cooper ER. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci. 2003;18:113–20.
10. Bruno RP, McIlwrick R. Microfluidizer processor technology for high performance particle size reduction, mixing and dispersion. Eur J Pharm Biopharm. 1999;56:29–36.
11. Tunick MH, Van Hecken DL, Cooke PH, et al. Transmission electron microscopy of mozzarella cheeses made from microfluidized milk. J Agric Food Chem. 2002;50:99–103.
12. Mijajlovic M, Wright D, Zivkovic V, Bi JX, Biggs MJ. Microfluidic hydrodynamic focusing based synthesis of POPC liposomes for model biological systems. Colloids Surf B: Biointerfaces. 2013;104:276–81.
13. Hung LH, Lee AP. Microfluidic devices for the synthesis of nanoparticles and biomaterials. J of Med Biol Eng. 2007;27:1–6.
14. Park J, Saffari A, Kumar S, Gunther A, Kumacheva E, Clarke DR, et al. Microfluidic synthesis of polymer and inorganic particulate materials. Ann Rev Mat Res. 2010;40:415–43.
15. Napoli M, Atzberger P, Pennathur S. Experimental study of the separation behavior of nanoparticles in micro- and nanochannels. Microfluid Nanofluid. 2011;10:69–80.
16. Xing T, Sunarso J, Yang W, Yin Y, Glushenkov AM, Li LH, et al. Ball milling: a green mechanochemical approach for synthesis of nitrogen doped carbon nanoparticles. Nanoscale. 2013;5:7970–6.
17. Aydin E, Planell JA, Hasirci V. Hydroxyapatite nanorod-reinforced biodegradable poly(Llactic acid) composites for bone plate applications. J Mater Sci Mater Med. 2011;22:2413–27.
18. Guo P, Hsu TM, Zhao Y, Martin CR, Zare RN. Preparing amorphous hydrophobic drug nanoparticles by nanoporous membrane extrusion. Nanomedicine (Lond). 2013;8:333–41.
19. Khinast J, Baumgartner R, Roblegg E. Nano-extrusion: a one-step process for manufacturing of solid nanoparticle formulations directly from the liquid phase. AAPS PharmSciTech. 2013;14:601–4.
20. Elizondo E, Veciana J, Ventosa N. Nanostructuring molecular materials as particles and vesicles for drug delivery, using compressed and supercritical fluids. Nanomedicine (Lond). 2012;7:1391–408.
21. Sheth P, Sandhu H, Singhal D, Malick W, Shah N, Kislalioglu MS. Nanoparticles in the pharmaceutical industry and the use of supercritical fluid technologies for nanoparticle production. Curr Drug Deliv. 2012;9:269–84.
22. Byrappa K, Ohara S, Adschiri T. Nanoparticles synthesis using supercritical fluid technology—towards biomedical applications. Adv Drug Deliv Rev. 2008;60:299–327.
23. Sun YP, Meziani MJ, Pathak P, Qu L. Polymeric nanoparticles from rapid expansion of supercritical fluid solution. Chemistry. 2005;11:1366–73.
24. Mendoza-Muñoz N, Quintanar-Guerrero D, Allémann E. The impact of the salting out technique on the preparation of colloidal particulate systems for pharmaceutical applications. Recent Pat Drug Deliv Formul. 2012;3:236–49.
25. Galindo-Rodríguez SA, Puel F, Briançon S, Allémann E, Doelker E, Fessi H. Comparative scale-up of three methods for producing ibuprofen-loaded nanoparticles. Eur J Pharm Sci. 2005;25(4):357–67.
26. Fàbregas A, Miñarro M, García-Montoya E, Pérez-Lozano P, Carrillo C, Sarrate R, et al. Impact of physical parameters on particle size and reaction yield when using the ionic gelation method to obtain cationic polymeric chitosan-tripolyphosphate nanoparticles. Int J Pharm. 2013;446:199–204.
27. Fuchs S, Winter G, Coester C. Ultrasonic resonator technology as a new quality control method evaluating gelatin nanoparticles. J Microencapsul. 2010;27:242–52.
28. Corrias F, Lai F. New methods for lipid nanoparticles preparation. Recent Pat Drug Deliv Formul. 2011;5:201–13.
29. Rai S, Paliwal R, Gupta PN, Khatri K, Goyal AK, Vaidya B, et al. Solid lipid nanoparticles (SLNs) as a rising tool in drug delivery science: one step up in nanotechnology. Curr Nanosci. 2008;4:30–44.
30. Lamprecht A, Ubrich N, Hombreiro Pérez M, Lehr C, Hoffman M, Maincent P. Biodegradable mono dispersed nanoparticles prepared by pressure homogenization emulsification. Int J Pharm. 1999;184:97–105.
31. Hou D, Xie C, Huang K, Zhu C. The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials. 2003;24:1781–5.
32. Gasco MR. Method for producing solid lipid microspheres having a narrow size distribution. United States patent, US 188837. 1993. 5.
33. Xie S, Wang S, Zhao B, Han C, Wang M, Zhou W. Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles. Colloids Surf B: Biointerfaces. 2008;67:199–204.
34. Trotta M, Debernardi F, Caputo O. Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique. Int J Pharm. 2003;257:153–60.
35. Charcosset C, El-Harati A, Fessi H. Preparation of solid lipid nanoparticles using a membrane contactor. J Control Release. 2005;108:112–20.
36. Bose S, Michniak-Kohn B. Preparation and characterization of lipid based nanosystems for topical delivery of quercetin. Eur J Pharm Sci. 2012;48:442–52.
37. Lamprecht A, Ubrich N, Hombreiro Pérez M, Lehr C, Hoffman M, Maincent P. Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique. Int J Pharm. 2000;196:177–82.
38. Ghosh P, Han G, De M, Kim CK, Rotello VM. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev. 2008;60:1307–15.
39. Hu H, Nie L, Feng S, Suo J. Preparation, characterization and in vitro release study of gallic acid loaded silica nanoparticles for controlled release. Pharmazie. 2013;68:401–5.
40. Bianco A, Kostarelos K, Prato M. Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol. 2005;9:674–9.
41. Burnett K, Tyshenko MG. A comparison of human capital levels and the future prospect of the nanotechnology industry in early sector investors and recent emerging markets. Intl J of Nanotech. 2010;7:187–208.
42. Vladisavljevic GT, Khalid N, Neves MA, Kuroiwa T, Nakajima M, Uemura K, et al. Industrial lab-on-a-chip: design, applications and scale-up for drug discovery and delivery. Adv Drug Deliv Rev. 2013;65(11–12):1626–63.
43. Hock SC, Ying YM, Wah CL. A review of the current scientific and regulatory status of nanomedicines and the challenges ahead. PDA J Pharm Sci Technol. 2011;65:177–95.
44. Buzea C, Pacheco II, Robbie K. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases. 2007;2(4):MR17–MR7.
45. Colombo A, Briançon S, Lieto J, Fessi H. Project, design, and use of a pilot plant for nanocapsule production. Drug Dev Ind Pharm. 2001;27(10):1063–72.
46. Wagner V, Dullaart A, Bock A-K, Zweck A. The emerging nanomedicine landscape. Nat Biotechnol. 2006;24(10):1211–8.